Singapore Busts Illicit Vape Production; Suspect Charged with Five Offenses

Jul.18.2025
Singapore Busts Illicit Vape Production; Suspect Charged with Five Offenses
A 41-year-old man in Singapore has been charged with multiple offenses, including violations of the Tobacco (Control of Advertisements and Sale) Act and the Poisons Act, for allegedly manufacturing e-cigarettes containing the controlled substance etizolam at his residence.

Key points:

 

·A 41-year-old man in Singapore is facing charges for allegedly manufacturing e-cigarettes containing drugs. 

 

·He is accused of violating the Tobacco (Control of Advertisements and Sale) Act. Over a thousand e-cigarette components and a large quantity of empty pods were seized from him. 

 

·The man has expressed his intention to plead guilty and is scheduled to appear in court on July 23rd.

 


【2Firsts News Flash】According to a report by Malaymail on July 17, a 41-year-old man in Singapore is being accused of illegally manufacturing e-cigarettes containing drugs in his home. The defendant, Mohammed Akil Abdul Rahim, is facing five charges under the Tobacco (Control of Advertisements and Sale) Act for allegedly manufacturing e-cigarettes in a block of flats in Yishun.

 

The accusation documents show that on December 11, 2024, law enforcement officers found 569 empty pod casings, 534 components, 1,485 pod covers, and 100 electronic pods at his residence. These tools and materials are believed to be used in the manufacturing of Kpodspods laced with fentanyl, which has garnered increasing public concern.

 

The prosecutor from the Health Sciences Authority (HSA) in Singapore told the court that they have prepared a plea agreement for the case. The defendant appeared in court via video link and expressed willingness to plead guilty to all charges, and stated that he does not plan to hire a lawyer.

 

The man was previously charged under the Poisons Act for possession and sale of the controlled hospital-grade sedative, etomidate. It is alleged that he sold 100 electronic pods containing the substance at the same location just past midnight on December 11. He was found in possession of 26.4 grams of white powder testing positive for the substance at around 5:30am that same morning.

 

Propofol is commonly used for intravenous sedation in medical procedures, but if inhaled or ingested, it can lead to serious side effects including seizures, difficulty breathing, and confusion.

 

In addition, the defendant also faces charges under the Passport Act for falsely claiming to the Immigration and Checkpoints Authority in January 2025 that he had lost his passport at a coffee shop. He has been in custody since June 20 and is expected to plead guilty on July 23.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Belgium: BAT plans to cut 51 jobs at Groot-Bijgaarden site
Belgium: BAT plans to cut 51 jobs at Groot-Bijgaarden site
British American Tobacco (BAT) has announced plans to cut 51 jobs at its Groot-Bijgaarden facility in Belgium, disclosed during a special works council meeting.
Jan.15 by 2FIRSTS.ai
FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
During its ongoing PMTA roundtable, FDA emphasized that product characterization is a foundational element in the review of electronic nicotine delivery systems (ENDS). The agency underscored the need for complete product identifying information, validation and verification of test methods on the specific product type, and the appropriate use of tobacco product master files (TPMFs) to support complex or proprietary ingredients in PMTA submissions.
Feb.10
Special Report | China’s New Five-Year Plan Highlights “Health-First” Strategy, Providing Policy Context for Tobacco Sector
Special Report | China’s New Five-Year Plan Highlights “Health-First” Strategy, Providing Policy Context for Tobacco Sector
China’s 2026 “Two Sessions” reviewed the draft Outline of the 15th Five-Year Plan, which proposes implementing a health-first development strategy and strengthening the effectiveness of the Patriotic Health Campaign. Although the document does not address specific industries, this public-health governance framework provides a new policy context for observing the future regulation, product strategies, and market development of China’s tobacco and next-generation nicotine sectors.
Industry Insight
Mar.08
PMI Faces Setback in India: Global Regulatory Fragmentation Complicates Its Smoke-Free Transition
PMI Faces Setback in India: Global Regulatory Fragmentation Complicates Its Smoke-Free Transition
India has reaffirmed its 2019 ban on e-cigarettes and heated tobacco devices, effectively blocking Philip Morris International (PMI) from launching IQOS in the country despite years of lobbying. Together with Taiwan, China’s conditional opening of heated tobacco products, and Japan’s planned 2026 excise tax hikes, these moves highlight increasingly divergent national regulatory pathways—an external uncertainty shaping PMI’s smoke-free growth trajectory.
Feb.12
Japan Tobacco seeks retail price hike for Ploom tobacco sticks; EVO and others to rise by 30 yen per pack
Japan Tobacco seeks retail price hike for Ploom tobacco sticks; EVO and others to rise by 30 yen per pack
Japan Tobacco (JT) said it has applied to raise retail prices for its heated tobacco-related products from April 1, 2026, covering 37 variants of Ploom tobacco sticks and with capsules, with most increases at 20–30 yen per pack (about $0.13–$0.19).
Jan.28 by 2FIRSTS.ai
Syria announces comprehensive ban on e-cigarettes covering production, trade, sale and use
Syria announces comprehensive ban on e-cigarettes covering production, trade, sale and use
Syria Damascus health authorities announced a comprehensive ban on e-cigarettes, prohibiting their production, circulation, sale and use, citing health risks and the need to protect public health, particularly among children and young people.
Mar.02 by 2FIRSTS.ai